Business · 27/11/2017
FDA Hosts Public Workshop on Safety Assessment for IND Safety Reporting
The FDA is hosting a public workshop to discuss the draft guidance on Safety Assessment for Investigational New Drug Safety Reporting, following public comments received on the draft guidance issued in December 2015.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →